Halberd Co. (OTCMKTS:HALB) Sees Significant Increase in Short Interest

Halberd Co. (OTCMKTS:HALB) was the recipient of a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 123,900 shares, a growth of 6,783.3% from the August 31st total of 1,800 shares. Based on an average daily volume of 2,266,100 shares, the days-to-cover ratio is presently 0.1 days.

Halberd Stock Performance

Shares of OTCMKTS HALB opened at $0.01 on Friday. Halberd has a 52 week low of $0.00 and a 52 week high of $0.01. The business’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.01.

About Halberd

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.